Pasgala, Christela N.
HRN: 22-00-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/02/2022
10/09/2022
IV
500 Mg
Q 8 HRS
TMSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes